Rosacea
Conditions
Keywords
Rosacea
Brief summary
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Rosacea patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Rosacea patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient is at least 18 years of age * Diagnosis of Rosacea * Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
Exclusion criteria
* Inability to perform regular electronic reporting * Women who are pregnant, intend to become pregnant, or are lactating * Enrolled in another research study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to join in an Rosacea clinical study | 3 months |
| Number of Rosacea patients who remain in clinical trial until completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed